“…This is of potential great clinical relevance since adhesion of aberrant PC to extracellular matrix proteins confers cell adhesion-mediated drug resistance, and triggers BM accessory cells to secrete cytokines (e.g. IL-6, IGF-1, VEGF, BAFF, SDF-1a, and TNFa) which on one side promote PC growth, survival, and migration, at the same time they also confer resistance to conventional chemotherapy (86,87), osteoclastogenesis and angiogenesis (88,89). Because of this, the potential significance of the expression of several markers involved in the interaction between clonal PC and BM stromal cells is currently under investigation; of note, interesting results have already emerged from those studies as regards VLA-4 (90,91), ICAM-1 (CD54) (92), and CD44 (93,94) staining on aberrant PC and their association with the BM PC niches.…”